BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25832305)

  • 1. Quality compared to quantity of life in laryngeal cancer: A time trade-off study.
    Hamilton DW; Bins JE; McMeekin P; Pedersen A; Steen N; De Soyza A; Thomson R; Paleri V; Wilson JA
    Head Neck; 2016 Apr; 38 Suppl 1():E631-7. PubMed ID: 25832305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of attitudes to laryngeal cancer treatment outcomes: A time trade-off study.
    Hamilton DW; Pedersen A; Blanchford H; Bins JE; McMeekin P; Thomson R; Paleri V; Wilson JA
    Clin Otolaryngol; 2018 Feb; 43(1):117-123. PubMed ID: 28544805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life After Conservation Surgery for Laryngeal Cancer.
    Sadoughi B
    Otolaryngol Clin North Am; 2015 Aug; 48(4):655-65. PubMed ID: 26092764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer.
    Laccourreye O; Mirghani H; Guiquerro S; Quer M; Giraud P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Mar; 140(2):77-80. PubMed ID: 36642664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.
    Timmermans AJ; van Dijk BA; Overbeek LI; van Velthuysen ML; van Tinteren H; Hilgers FJ; van den Brekel MW
    Head Neck; 2016 Apr; 38 Suppl 1():E1247-55. PubMed ID: 26315454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otorhinolaryngologists' personal treatment preferences (total laryngectomy or laryngeal preservation) when faced with advanced stage laryngeal cancer.
    Laccourreye O; Malinvaud D; Ménard M; Consoli S; Giraud P; Bonfils P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):339-343. PubMed ID: 24993784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
    Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
    Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomy.
    Trivedi NP; Swaminathan DK; Thankappan K; Chatni S; Kuriakose MA; Iyer S
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):702-7. PubMed ID: 18984267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal cancer.
    Tomeh C; Holsinger FC
    Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):147-53. PubMed ID: 24504224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
    Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
    Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
    Zhu J; Fedewa S; Chen AY
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
    Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal preservation in head and neck cancer: multidisciplinary approach.
    Lefebvre JL
    Lancet Oncol; 2006 Sep; 7(9):747-55. PubMed ID: 16945770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
    Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol.
    Timmermans AJ; de Gooijer CJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Head Neck; 2015 Oct; 37(10):1495-503. PubMed ID: 24891221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic outcomes of supratracheal laryngectomy: Critical analysis.
    Rizzotto G; Crosetti E; Lucioni M; Bertolin A; Monticone V; Sprio AE; Berta GN; Succo G
    Head Neck; 2015 Oct; 37(10):1417-24. PubMed ID: 24839082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.